{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:24:45Z","timestamp":1790270685715,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"IMSS Fund for the Promotion of Health Research","award":["FIS\/IMSS\/PROT\/G17-211759"],"award-info":[{"award-number":["FIS\/IMSS\/PROT\/G17-211759"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In Mexico, patients with hematologic malignancies (HMs) are characterized by being at high risk and advanced stages at diagnosis and by having a low cure rate; yet information on their experiences with health care and health-related quality of life (HRQL) is scarce. We aimed to evaluate experiences with health care and HRQL of patients with HMs and the association between these patient-reported measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional survey in two public oncology hospitals in Mexico City. The study included outpatient cancer patients aged \u226518\u2009years with a diagnosis of leukemia, lymphoma, or multiple myeloma. We used a patient-centered quality of cancer care questionnaire to assess patient experiences with receiving 1) timely care; 2) clear information; 3) information for treatment decision-making; 4) care to address biopsychosocial needs; and 5) respectful and coordinated care. We applied the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) to measure HRQL. We performed a multiple linear regression to evaluate the association between patient-reported experiences (independent variables) and the QLQ-C30 summary score (dependent variable).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 515 participating HM patients, 46.6% had lymphoma, 34% leukemia, and 19.4% multiple myeloma; 70.9% were at advanced stages or at high risk. Additionally, 15.1% had anxiety and 12.8% had depression. Over one third (35.9%) reported receiving clear information, 28.5% timely care, 20.6% information for treatment decision-making, 23.7% care that addressed their biopsychosocial needs, and 31% respectful and coordinated care. The mean QLQ-C30 summary score was 71.9 points. Timely care, clear information, and care that addresses biopsychosocial needs were associated with higher HRQL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Health care services for HM patients at public oncology hospitals in Mexico need improvement. Notably, providing timely care, clear information, and care that addresses patients\u2019 biopsychosocial needs can increase the likelihood of better HRQL. Health care providers should measure and improve the experiences of HM patients with health care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-020-05498-7","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T08:02:51Z","timestamp":1594368171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0521-7095","authenticated-orcid":false,"given":"Svetlana V.","family":"Doubova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Terreros-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Delgado-L\u00f2pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efreen Horacio","family":"Monta\u00f1o-Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Infante-Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"P\u00e9rez-Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"5498_CR1","unstructured":"The Global Cancer Observatory. Cancer today. Publishing WHOweb, 2019. https:\/\/gco.iarc.fr Accessed 10 Mar 2020."},{"key":"5498_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.19.11000","volume":"5","author":"V Tietsche de Moraes Hungria","year":"2019","unstructured":"Tietsche de Moraes Hungria V, Chiattone C, Pavlovsky M, et al. Epidemiology of hematologic malignancies in real-world settings: findings from the hemato-oncology latin America observational registry study. J Glob Oncol. 2019;5:1\u201319 https:\/\/ascopubs.org\/doi\/10.1200\/JGO.19.00025 Accessed 8 Jan 2020.","journal-title":"J Glob Oncol"},{"key":"5498_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.arcmed.2015.07.004","volume":"46","author":"JC Jaime-Perez","year":"2015","unstructured":"Jaime-Perez JC, Gamboa-Alonso CM, Vazquez-Mellado de Larracoechea A, et al. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma. Arch Med Res. 2015;46:454\u201361.","journal-title":"Arch Med Res"},{"key":"5498_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clml.2016.08.013","volume":"17","author":"JC Jaime-P\u00e9rez","year":"2017","unstructured":"Jaime-P\u00e9rez JC, Jim\u00e9nez-Castillo RA, Herrera-Garza JL, et al. Survival rates of adults with acute lymphoblastic leukemia in a low-income population: a decade of experience at a single institution in Mexico. Clin Lymphoma Myeloma Leuk. 2017;17:60\u20138.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"5498_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bjhh.2017.08.001","volume":"39","author":"JC Jaime-P\u00e9rez","year":"2017","unstructured":"Jaime-P\u00e9rez JC, Gamboa-Alonso CM, Padilla-Medina JR, et al. High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center. Rev Bras Hematol Hemoter. 2017;39:325\u201330.","journal-title":"Rev Bras Hematol Hemoter"},{"key":"5498_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/ijc.28049","volume":"133","author":"L Chatenoud","year":"2013","unstructured":"Chatenoud L, Bertuccio P, Bosetti C, et al. Hodgkin's lymphoma mortality in the Americas, 1997\u20132008: achievements and persistent inadequacies. Int J Cancer. 2013;133:687\u201394.","journal-title":"Int J Cancer"},{"key":"5498_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00277-011-1274-4","volume":"90","author":"S Oerlemans","year":"2011","unstructured":"Oerlemans S, Mols F, Nijziel MR, et al. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review. Ann Hematol. 2011;90:993\u20131004.","journal-title":"Ann Hematol"},{"key":"5498_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cncr.22365","volume":"109","author":"RA Mesa","year":"2007","unstructured":"Mesa RA, Niblack J, Wadleigh M, et al. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international internet-based survey of 1179MPD patients. Cancer. 2007;109:68\u201376.","journal-title":"Cancer"},{"key":"5498_CR9","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1080\/10428190500244183","volume":"46","author":"S Molica","year":"2005","unstructured":"Molica S. Quality of life in chronic lymphocytic leukemia: a neglected issue. Leuk Lymphoma. 2005;46:1709\u201314.","journal-title":"Leuk Lymphoma"},{"key":"5498_CR10","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3324\/haematol.11710","volume":"92","author":"F Efficace","year":"2007","unstructured":"Efficace F, Novik A, Vignetti M, Mandelli F, Cleeland CS. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here? Haematologica. 2007;92:1596\u20138.","journal-title":"Haematologica."},{"key":"5498_CR11","volume-title":"A New Health System for the 21st Century. In Committee on Quality of Healthcare in America. Crossing the Quality Chasm","author":"Institute of Medicine","year":"2001","unstructured":"Institute of Medicine. A New Health System for the 21st Century. In Committee on Quality of Healthcare in America. Crossing the Quality Chasm. Whashington: Academy Press; 2001. http:\/\/www.nap.edu\/openbook.php?isbn=0309072808 Accessed 8 Jan 2020."},{"key":"5498_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1077558712465774","volume":"70","author":"C Rathert","year":"2013","unstructured":"Rathert C, Wyrwich MD, Boren SA. Patient-centered care and outcomes: a systematic review of the literature. Med Care Res Rev. 2013;70:351\u201379.","journal-title":"Med Care Res Rev"},{"key":"5498_CR13","doi-asserted-by":"publisher","unstructured":"Liang H, Tao L, Ford EW, et al. The patient-centered oncology care on health care utilization and cost: a systematic review and meta-analysis. Health Care Manag Rev. 2018. https:\/\/doi.org\/10.1097\/HMR.0000000000000226 Accessed 10 Mar 2020.","DOI":"10.1097\/HMR.0000000000000226"},{"key":"5498_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.pec.2009.09.015","volume":"77","author":"MK Venetis","year":"2009","unstructured":"Venetis MK, Robinson JD, Turkiewicz KL, et al. An evidence base for patient-centered cancer care: a meta-analysis of studies of observed communication between cancer specialists and their patients. Patient Educ Couns. 2009;77:379\u201383.","journal-title":"Patient Educ Couns"},{"issue":"10","key":"5498_CR15","doi-asserted-by":"publisher","first-page":"e1002673","DOI":"10.1371\/journal.pmed.1002673","volume":"15","author":"F Guanais","year":"2018","unstructured":"Guanais F, Doubova SV, Leslie HH, et al. Patient-centered primary care and self-rated health in 6 Latin American and Caribbean countries: Analysis of a public opinion cross-sectional survey. PLoS Med. 2018;15(10):e1002673. https:\/\/doi.org\/10.1371\/journal.pmed.1002673 Accessed 1 Feb 2020.","journal-title":"PLoS Med"},{"key":"5498_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/bjaed\/mkw060","volume":"17","author":"C Kingsley","year":"2017","unstructured":"Kingsley C, Patel S. Patient-reported outcome measures and patient-reported experience measures. BJA Education. 2017;17:137\u201344.","journal-title":"BJA Education"},{"key":"5498_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2147\/PPA.S81975","volume":"9","author":"F Tzelepis","year":"2015","unstructured":"Tzelepis F, Sanson-Fisher RW, Zucca AC, et al. Measuring the quality of patient-centered care: why patient-reported measures are critical to reliable assessment. Patient Prefer Adherence. 2015;9:831\u20135.","journal-title":"Patient Prefer Adherence"},{"key":"5498_CR18","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.pec.2019.04.028","volume":"102","author":"TW LeBlanc","year":"2019","unstructured":"LeBlanc TW, Baile WF, Eggly S, et al. Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies. Patient Educ Couns. 2019;102:1602\u201312.","journal-title":"Patient Educ Couns"},{"issue":"Supplement 1","key":"5498_CR19","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1182\/blood.V130.Suppl_1.4704.4704","volume":"130","author":"AK Zaleta","year":"2017","unstructured":"Zaleta AK, Miller MF, Johnson J, et al. Symptom burden, palliative care needs, and patient-provider communication among chronic myeloid leukemia survivors. Blood. 2017;130(Supplement 1):4704. https:\/\/doi.org\/10.1182\/blood.V130.Suppl_1.4704.4704 Accessed 10 Mar 2020.","journal-title":"Blood"},{"key":"5498_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.leukres.2008.06.019","volume":"33","author":"TD Shanafelt","year":"2009","unstructured":"Shanafelt TD, Bowen DA, Venkat C, et al. The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res. 2009;33:263\u201370.","journal-title":"Leuk Res"},{"key":"5498_CR21","first-page":"62","volume":"12","author":"JC Jaime-P\u00e9rez","year":"2011","unstructured":"Jaime-P\u00e9rez JC, Sandoval-Villa CC, Marfil-Rivera LJ, et al. Quality of life in patients with hematological diseases in Northeast Mexico. Rev Hematol Mex. 2011;12:62\u20137.","journal-title":"Rev Hematol Mex"},{"key":"5498_CR22","doi-asserted-by":"publisher","unstructured":"Jaime-P\u00e9rez JC, Turrubiates-Hern\u00e1ndez GA, Nava-Obreg\u00f3n T, et al. Palliative care for patients with hematologic malignancies in a low-middle income country: prevalence of symptoms and the need for improving quality of attention at the end of life. Am J Hosp Palliat Care. 2019. https:\/\/doi.org\/10.1177\/1049909119887951.","DOI":"10.1177\/1049909119887951"},{"key":"5498_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1590\/S0080-62342013000200012","volume":"47","author":"V Andrade","year":"2013","unstructured":"Andrade V, Sawada NO, Barichello E. Quality of life in hematologic oncology patients undergoing chemotherapy. Rev Esc Enferm USP. 2013;47:355\u201361.","journal-title":"Rev Esc Enferm USP"},{"key":"5498_CR24","doi-asserted-by":"publisher","first-page":"e13067","DOI":"10.1111\/ecc.13067","volume":"28","author":"A Immanuel","year":"2019","unstructured":"Immanuel A, Hunt J, McCarthy H, van Teijlingen E, Sheppard ZA. Quality of life in survivors of adult haematological malignancy. Eur J Cancer Care (Engl). 2019;28:e13067. https:\/\/doi.org\/10.1111\/ecc.13067.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"5498_CR25","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00520-013-1775-x","volume":"21","author":"A Soares","year":"2013","unstructured":"Soares A, Biasoli I, Scheliga A, et al. Association of social network and social support with health-related quality of life and fatigue in long-term survivors of Hodgkin lymphoma. Support Care Cancer. 2013;21:2153\u20139. https:\/\/doi.org\/10.1007\/s00520-013-1775-x.","journal-title":"Support Care Cancer"},{"key":"5498_CR26","unstructured":"Instituto Mexicano del Seguro Social. Informe al Ejecutivo Federal y al Congreso de la Uni\u00f3n sobre la situaci\u00f3n financiera y los riesgos del Instituto Mexicano del Seguro Social 2017\u20132018.8 M\u00e9xico, 2018. http:\/\/www.imss.gob.mx\/sites\/all\/statics\/pdf\/informes\/20172018\/21-InformeCompleto.pdf Accessed 1 Feb 2020."},{"key":"5498_CR27","doi-asserted-by":"publisher","first-page":"e033114","DOI":"10.1136\/bmjopen-2019-033114","volume":"10","author":"SV Doubova","year":"2020","unstructured":"Doubova SV, Mart\u00ednez-Vega IP, Guti\u00e9rrez-De-la-Barrera M, et al. Psychometric validation of a patient-centered quality of cancer care questionnaire in Mexico. BMJ Open. 2020;10:e033114. https:\/\/doi.org\/10.1136\/bmjopen-2019-033114.","journal-title":"BMJ Open"},{"key":"5498_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"5498_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","volume":"69","author":"JM Giesinger","year":"2016","unstructured":"Giesinger JM, Kieffer JM, Fayers PM, et al. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol. 2016;69:79\u201388.","journal-title":"J Clin Epidemiol"},{"key":"5498_CR30","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jval.2019.06.004","volume":"22","author":"F Efficace","year":"2019","unstructured":"Efficace F, Cottone F, Sommer K, et al. Validation of the European Organisation for Research and Treatment of Cancer quality of life questionnaire Core 30 summary score in patients with hematologic malignancies. Value Health. 2019;22:1303\u201310.","journal-title":"Value Health"},{"key":"5498_CR31","doi-asserted-by":"publisher","unstructured":"Husson O, de Rooij BH, Kieffer J, et al. The EORTC QLQ-C30 summary score as prognostic factor for survival of patients with Cancer in the \u201creal-world\u201d: results from the population-based PROFILES registry. Oncologist. 2019. https:\/\/doi.org\/10.1634\/theoncologist.2019-0348.","DOI":"10.1634\/theoncologist.2019-0348"},{"key":"5498_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.17711\/SM.0185-3325.2015.035","volume":"38","author":"O Galindo V\u00e1zquez","year":"2015","unstructured":"Galindo V\u00e1zquez O, Benjet C, Ju\u00e1rez Garc\u00eda F, et al. Psychometric properties of the hospital anxiety and depression scale (HADS) in a Mexican population of cancer patients. Salud Mental. 2015;38:253\u20138.","journal-title":"Salud Mental"},{"key":"5498_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"A Zigmond","year":"1983","unstructured":"Zigmond A, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"5498_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.20982\/tqmp.03.2.p043","volume":"3","author":"CR Wilson-VanVoorhis","year":"2007","unstructured":"Wilson-VanVoorhis CR, Morgan BL. Understanding power and rules of thumb for determining sample sizes. Tutor Quant Methods Psychol. 2007;3:43\u201350.","journal-title":"Tutor Quant Methods Psychol"},{"key":"5498_CR35","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/j.1541-0420.2011.01619.x","volume":"67","author":"TJ VanderWeele","year":"2011","unstructured":"VanderWeele TJ, Shpitser I. A new criterion for confounder selection. Biometrics. 2011;67:1406\u201313.","journal-title":"Biometrics."},{"key":"5498_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B, Tibshirani R. An introduction to the bootstrap. New York: Chapman & Hall; 1993."},{"key":"5498_CR37","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3389\/fpsyg.2018.02104","volume":"9","author":"J Pek","year":"2018","unstructured":"Pek J, Wong O, Wong ACM. How to address non-normality: a taxonomy of approaches, reviewed, and illustrated. Front Psychol. 2018;9:2104. https:\/\/doi.org\/10.3389\/fpsyg.2018.02104.","journal-title":"Front Psychol"},{"key":"5498_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejca.2019.08.016","volume":"121","author":"A Bottomley","year":"2019","unstructured":"Bottomley A, Reijneveld JC, Koller M, et al. 5th EORTC quality of life in cancer clinical trials conference faculty. Current state of quality of life and patient-reported outcomes research. Eur J Cancer. 2019;121:55\u201363.","journal-title":"Eur J Cancer"},{"key":"5498_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00520-008-0505-2","volume":"17","author":"SY Zafar","year":"2009","unstructured":"Zafar SY, Alexander SC, Weinfurt KP, et al. Decision making and quality of life in the treatment of cancer: a review. Support Care Cancer. 2009;17:117\u201327.","journal-title":"Support Care Cancer"},{"key":"5498_CR40","doi-asserted-by":"publisher","first-page":"e1196","DOI":"10.1016\/S2214-109X(18)30386-3","volume":"6","author":"ME Kruk","year":"2018","unstructured":"Kruk ME, Gage AD, Arsenault C, et al. High-quality health systems in the sustainable development goals era: time for a revolution. Lancet Glob Health. 2018;6:e1196\u2013252.","journal-title":"Lancet Glob Health"},{"key":"5498_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.pec.2006.05.003","volume":"63","author":"C Bieber","year":"2006","unstructured":"Bieber C, M\u00fcller KG, Blumenstiel K, et al. Long-term effects of a shared decision-making intervention on physician-patient interaction and outcome in fibromyalgia. A qualitative and quantitative 1 year follow-up of a RCT. Patient Educ Couns. 2006;63:357\u201366.","journal-title":"Patient Educ Couns"},{"key":"5498_CR42","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jpainsymman.2018.08.011","volume":"56","author":"OP Geerse","year":"2018","unstructured":"Geerse OP, Stegmann ME, Kerstjens HAM, et al. Effects of shared decision making on distress and health care utilization among patients with lung Cancer: a systematic review. J Pain Symptom Manag. 2018;56:975\u201387.","journal-title":"J Pain Symptom Manag"},{"key":"5498_CR43","first-page":"4633","volume":"10","author":"M Truglio-Londrigan","year":"2012","unstructured":"Truglio-Londrigan M, Slyer JT, Singleton JK, et al. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings. JBI Libr Syst Rev. 2012;10:4633\u201346.","journal-title":"JBI Libr Syst Rev"},{"issue":"3","key":"5498_CR44","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0889-8588(02)00022-9","volume":"16","author":"MH Tattersall","year":"2002","unstructured":"Tattersall MH, Butow PN, Clayton JM. Insights from cancer patient communication research. Hematol Oncol Clin North Am. 2002;16(3):731\u201343.","journal-title":"Hematol Oncol Clin North Am"},{"key":"5498_CR45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/0272989X9701700306","volume":"17","author":"RL Street Jr","year":"1997","unstructured":"Street RL Jr, Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decis Mak. 1997;17:298\u2013306.","journal-title":"Med Decis Mak"},{"key":"5498_CR46","doi-asserted-by":"publisher","unstructured":"Tzelepis F, Clinton-McHarg T, Paul CL, et al. Quality of patient-centered care provided to patients attending hematological cancer treatment centers. Int J Environ Res Public Health. 2018;15(3). https:\/\/doi.org\/10.3390\/ijerph15030549.","DOI":"10.3390\/ijerph15030549"},{"issue":"5 Suppl 1","key":"5498_CR47","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.jval.2011.05.026","volume":"14","author":"LM Balderas-Pe\u00f1a","year":"2011","unstructured":"Balderas-Pe\u00f1a LM, Sat-Mu\u00f1oz D, Contreras-Hern\u00e1ndez I, et al. Evaluation of patient satisfaction with the quality of health care received within the EORTC IN-PATSAT32 trial by patients with breast and colorectal cancer, and non-Hodgkin lymphoma at different stages. Correlation with sociodemographic characteristics, comorbidities and other procedural variables at the Mexican Institute of Social Security. Value Health. 2011;14(5 Suppl 1):S96\u20139.","journal-title":"Value Health"},{"key":"5498_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/pubmed\/23.3.227","volume":"23","author":"CJ McPherson","year":"2001","unstructured":"McPherson CJ, Higginson IJ, Hearn J. Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. J Pub Health Med. 2001;23:227\u201334.","journal-title":"J Pub Health Med"},{"key":"5498_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13104-015-1188-7","volume":"8","author":"AE Hall","year":"2015","unstructured":"Hall AE, Sanson-Fisher RW, Lynagh MC, et al. What do haematological cancer survivors want help with? A cross-sectional investigation of unmet supportive care needs. BMC Res Notes. 2015;8:221. https:\/\/doi.org\/10.1186\/s13104-015-1188-7.","journal-title":"BMC Res Notes"},{"key":"5498_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.critrevonc.2013.03.008","volume":"88","author":"A Hall","year":"2013","unstructured":"Hall A, Lynagh M, Bryant J, et al. Supportive care needs of hematological cancer survivors: a critical review of the literature. Crit Rev Oncol Hematol. 2013;88:102\u201316.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"5498_CR51","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1097\/NCC.0000000000000492","volume":"41","author":"SV Doubova","year":"2018","unstructured":"Doubova SV, Casales-Hern\u00e1ndez MG, P\u00e9rez-Cuevas R. Supportive care needs and association with quality of life of Mexican adults with solid cancers. Cancer Nurs. 2018;41(2):E1\u201312.","journal-title":"Cancer Nurs"},{"key":"5498_CR52","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","volume":"48","author":"K Cocks","year":"2012","unstructured":"Cocks K, King MT, Velikova G, et al. Evidence-based guidelines for interpreting change scores for the European organisation for the research and treatment of Cancer quality of life questionnaire Core 30. Eur J Cancer. 2012;48:1713\u201321.","journal-title":"Eur J Cancer"},{"issue":"4","key":"5498_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3747\/co.19.981","volume":"19","author":"GC Turnbull Macdonald","year":"2012","unstructured":"Turnbull Macdonald GC, Baldassarre F, Brown P, et al. Psychosocial care for cancer: a framework to guide practice, and actionable recommendations for Ontario. Curr Oncol. 2012;19(4):209\u201316.","journal-title":"Curr Oncol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-020-05498-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T20:10:20Z","timestamp":1625861420000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05498-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5498"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05498-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-29181\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29181\/v2","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the IMSS National Research and Ethics Committee (registry number R-2017-785-042). Prior to each interview, participants received information about the aims and nature of the study and relevant ethical considerations. All invited participants agreed to participate and signed an informed consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"One of the authors SVD is an Associate Editor of BMC Health Services Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"644"}}